On the challenges of predicting treatment response in Hodgkin ’s Lymphoma using transcriptomic data

Despite the advancements in multiagent chemotherapy in the past years, up to 10% of Hodgkin ’s Lymphoma (HL) cases are refractory to treatment and, after remission, patients experience an elevated risk of death...
Source: BMC Medical Genomics - Category: Genetics & Stem Cells Authors: Tags: Research Source Type: research